Lack of clinically significant contact system activation during platelet concentrate filtration by leukocyte removal filters.
When blood (plasma) contacts certain foreign surfaces, factor XII can activate and trigger a series of reactions leading to cleavage of kininogens with subsequent release of bradykinin. In this study, we investigated two different widely used leukocyte removal filters, Pall PXL8K (A) and Asahi PLS-5A (B), to test whether clinically significant contact activation occurred during leukodepletion of platelet-rich plasma (PRP). Kininogens were measured by particle concentration fluorescence immunoassay (PCFIA), which can detect cleavage of high and low molecular weight kininogens (HK and LK), the parent molecules of bradykinin, to determine if contact activation had occurred. A slight, nonsignificant decrease in HK and LK was observed with filter A after the first 5 mL was filtered that returned to prefiltration levels by the end of the filtration. Specific TotK (the combined measurement of HK and LK heavy chains divided by plasma protein concentration) showed a small, significant decrease with filter A after the first 5 mL of platelet concentrates was filtered that returned to prefiltration levels by the end of the filtration. There were no significant increases or decreases in the cleaved kininogen index (CKI), an index of HK proteolytic activation or HK and LK destruction (with release of bradykinin). These data suggest that small amounts of both HK and LK initially adsorb to filter A and then desorb, primarily intact. These data also indicate that no significant contact activation, as measured by PCFIA, occurs during leukodepletion of platelet concentrates with either filter A or B.
Scott
C F
CF
Temple University School of Medicine, The Sol Sherry Thrombosis Research Center, Philadelphia, PA 19140, USA.
Brandwein
H
H
Whitbread
J
J
Colman
R W
RW
D001792:Blood Platelets / Q000473:pathology* / Q000502:physiology; D005374:Filtration / Q000295:instrumentation*; D006801:Humans; D007704:Kininogens / Q000032:analysis; D007962:Leukocytes / Q000473:pathology / Q000502:physiology; D015539:Platelet Activation; D010983:Plateletpheresis / Q000295:instrumentation* / Q000379:methods
D007704:Kininogens